 |
The development of effective inhibition of infectious organisms, cancer and sexually transmitted infections may ultimately involve a combination of products which target the organism as well as the intact human immune system. ImQuest recognizes the need to develop immunomodulatory agents to support drug development initiatives, as well as the potential ramifications of immune modulation to provide relief to millions that suffer from allergic and inflammatory diseases. ImQuest programs in biologics and small molecule immune modulators are designed to be used in combination with chemotherapeutic agents to fight infectious disease and cancer, but also to specifically target inflammatory disease.
|
| |
|
| Meet ImQuest Life Sciences's Staff at the Following Scientific Meetings: |
 |
International Conference on Antiviral Research (Palm Springs, CA, May 2007)
American Association of Pharmaceutical Science-Biotechnology (San Diego, CA June 2007)
|
|
DART-HIV (Cancun, Mexico, December 2006) |
|
Internscience Conference of Antimicrobial Agents and Chemotherapy (Chicago, September 2007)
DART-HCV (Hawaii, December 2007)
|
|
| |
|
